Document is current
Any future updates will be listed below
-
Authors
Sawadogo, Salam
Hwandih, Talent
Saker, Jarob
Coetzer, Thérèsa L.
Paszkowska, Anna
Kompaoré, Sidzabda C. B.
Münster, Marion
-
Funding
Funding for this research was provided by:
Sysmex Corporation Japan
- License Information
-
More Information
Article History
Received: 27 February 2025
Accepted: 17 September 2025
First Online: 23 September 2025
Declarations
:
: Study approval (2023-02-021)) was granted by the Burkina Faso Ethics Board of Health Research on behalf of the Ministry of Health and Public Hygiene, the Ministry of Higher Education, Research and Innovation on 24 February 2023. Informed consent was waived as there was no additional blood draw and consent to donate includes consent to use donated blood samples and biodata for research to improve blood safety and/or in studies of public health importance. Donors are informed that they can withdraw their consent for the use of their donated blood samples for research purposes, inherent in the general consent to donate blood, at any time pre- or post-donation. The malaria screening results were not linked to the individual blood units and thus did not influence the routine RBTC blood product selection and issuing procedures.
: Not applicable.
: TH, MM, and JS are full-time employees of Sysmex Europe SE who provided the analysers and reagents for the study. TLC provides consultancy services to Sysmex Europe SE. SS and SCDK received compensation from Sysmex Corporation Japan who funded the study. AP has no competing interests to declare.
